Mauna Kea Technologies SA
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions… Read more
Mauna Kea Technologies SA (MKEAF) - Net Assets
Latest net assets as of December 2024: $-24.39 Million USD
Based on the latest financial reports, Mauna Kea Technologies SA (MKEAF) has net assets worth $-24.39 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.25 Million) and total liabilities ($40.63 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-24.39 Million |
| % of Total Assets | -150.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -273.08% |
| Growth Volatility | 1695.51 |
Mauna Kea Technologies SA - Net Assets Trend (2013–2024)
This chart illustrates how Mauna Kea Technologies SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mauna Kea Technologies SA (2013–2024)
The table below shows the annual net assets of Mauna Kea Technologies SA from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-24.39 Million | -41.17% |
| 2023-12-31 | $-17.28 Million | +13.29% |
| 2022-12-31 | $-19.93 Million | -92.83% |
| 2021-12-31 | $-10.33 Million | +14.44% |
| 2020-12-31 | $-12.08 Million | -4873.52% |
| 2019-12-31 | $253.00K | -96.83% |
| 2018-12-31 | $7.98 Million | -52.35% |
| 2017-12-31 | $16.74 Million | +50.08% |
| 2016-12-31 | $11.16 Million | -20.82% |
| 2015-12-31 | $14.09 Million | -9.87% |
| 2014-12-31 | $15.63 Million | -48.16% |
| 2013-12-31 | $30.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mauna Kea Technologies SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 111200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.71 Million | % |
| Total Equity | $-24.39 Million | 100.00% |
Mauna Kea Technologies SA Competitors by Market Cap
The table below lists competitors of Mauna Kea Technologies SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
4Mass SA
WAR:4MS
|
$17.58 Million |
|
Pyxis Tankers Inc
NASDAQ:PXS
|
$17.60 Million |
|
Ryde Group Ltd.
NYSE MKT:RYDE
|
$17.60 Million |
|
African Rainbow Minerals Ltd
JSE:ARI
|
$17.61 Million |
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
$17.58 Million |
|
SMT Scharf AG
XETRA:S188
|
$17.57 Million |
|
Acer Gadget Inc
TW:2432
|
$17.57 Million |
|
J.D Development Co., LTD
TWO:4402
|
$17.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mauna Kea Technologies SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -17,277,000 to -24,389,000, a change of -7,112,000.
- Net loss of 10,404,000 reduced equity.
- New share issuances of 2,088,000 increased equity.
- Other comprehensive income increased equity by 23,614,000.
- Other factors decreased equity by 22,410,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.40 Million | -42.66% |
| Share Issuances | $2.09 Million | +8.56% |
| Other Comprehensive Income | $23.61 Million | +96.82% |
| Other Changes | $-22.41 Million | -91.89% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Mauna Kea Technologies SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.37 | x |
| 2016-12-31 | $0.00 | $0.37 | x |
| 2017-12-31 | $0.69 | $0.37 | x |
| 2018-12-31 | $0.32 | $0.37 | x |
| 2019-12-31 | $0.01 | $0.37 | x |
| 2020-12-31 | $-0.34 | $0.37 | x |
| 2021-12-31 | $-0.23 | $0.37 | x |
| 2022-12-31 | $-0.38 | $0.37 | x |
| 2023-12-31 | $-0.70 | $0.37 | x |
| 2024-12-31 | $-0.35 | $0.37 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mauna Kea Technologies SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -135.91%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-545.83%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -38.18% | -106.26% | 0.27x | 1.31x | $-14.53 Million |
| 2014 | -76.91% | -113.98% | 0.45x | 1.52x | $-13.59 Million |
| 2015 | -89.72% | -126.67% | 0.44x | 1.60x | $-14.05 Million |
| 2016 | -87.34% | -110.89% | 0.44x | 1.79x | $-10.86 Million |
| 2017 | -61.19% | -153.21% | 0.24x | 1.66x | $-11.92 Million |
| 2018 | -160.25% | -189.13% | 0.34x | 2.48x | $-13.58 Million |
| 2019 | -6036.36% | -179.48% | 0.36x | 93.36x | $-15.30 Million |
| 2020 | 0.00% | -196.00% | 0.32x | 0.00x | $-11.58 Million |
| 2021 | 0.00% | -174.61% | 0.31x | 0.00x | $-12.41 Million |
| 2022 | 0.00% | -149.49% | 0.38x | 0.00x | $-9.19 Million |
| 2023 | 0.00% | -33.80% | 0.48x | 0.00x | $-2.00 Million |
| 2024 | 0.00% | -135.91% | 0.47x | 0.00x | $-7.97 Million |
Industry Comparison
This section compares Mauna Kea Technologies SA's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mauna Kea Technologies SA (MKEAF) | $-24.39 Million | -38.18% | N/A | $17.58 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |